Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
- 1 October 2008
- journal article
- research article
- Published by Elsevier BV in Experimental Neurology
- Vol. 213 (2), 315-325
- https://doi.org/10.1016/j.expneurol.2008.06.004
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?Experimental Neurology, 2008
- Red Blood Cells Are the Major Source of Alpha-Synuclein in BloodNeurodegenerative Diseases, 2008
- Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body DiseaseJournal of Biological Chemistry, 2006
- Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivoNature Medicine, 2006
- CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementiaBrain, 2006
- CSF markers for incipient Alzheimer's diseaseThe Lancet Neurology, 2003
- Choroid plexus: Target for polypeptides and site of their synthesisMicroscopy Research and Technique, 2000
- Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine SystemNeuron, 2000
- Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapyProceedings of the National Academy of Sciences of the United States of America, 2000
- Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer DiseaseArchives of Neurology, 1999